doi:10.3969/j.issn.1004-583X.2023.08.014

Abstract

CLC Number:

R593.22

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2023.08.014

https://huicui.hebmu.edu.cn/EN/Y2023/V38/I8/753

References 31

[1]	Woude D, Houwing-Duistermaat JJ, Toes R, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis[J]. Arthritis Rheum, 2009, 60(4):916-923. doi: 10.1002/art.v60:4 URL
[2]	Frisell T, Holmqvist M, Kllberg H, et al. Familial risks and heritability of rheumatoid arthritis: Role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age[J]. Arthritis Rheum, 2013, 65(11): 2773-2782. doi: 10.1002/art.38097 URL
[3]	Thomas F, Karin H, Lars A, et al. Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: A register-based case-control study in Sweden[J]. Ann Rheum dis, 2016, 75(1):183-189. doi: 10.1136/annrheumdis-2014-206133 pmid: 25498119
[4]	Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis[J]. Nat Genet, 2012, 44(3):291-296. doi: 10.1038/ng.1076 pmid: 22286218
[5]	Woude D, Houwing-Duistermaat JJ, Toes R, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis[J]. Arthritis Rheum, 2009, 60(4):916-923. doi: 10.1002/art.v60:4 URL
[6]	High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis[J]. Nat Genet, 2012, 44(12):1336-1340. doi: 10.1038/ng.2462 pmid: 23143596
[7]	Wei WH, Viatte S, Merriman TR, et al. Genotypic variability based association identifies novel non-additive loci DHCR7 and IRF4 in sero-negative rheumatoid arthritis[J]. SciRep, 2017, 7(1): 5261.
[8]	Daniela DG, Discacciati A, Orsini N, Wolk A. Cigarette smoking and risk of rheumatoid arthritis: A dose-response meta-analysis[J]. Arthritis Res Ther, 2014, 16(2):R61. doi: 10.1186/ar4498 URL
[9]	Kronzer VL, Westerlind H, Alfredsson L, et al. Respiratory diseases as risk factors for seropositive and seronegative rheumatoid arthritis and in relation to smoking[J]. Arthritis Rheumatol, 2021, 73(1):61-68. doi: 10.1002/art.v73.1 URL
[10]	Wang QQ, Xu R. Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis[J]. BMC Genomics, 2019, 20(1):124. doi: 10.1186/s12864-019-5510-y pmid: 30744546
[11]	Honda K, Dan RL. The microbiome in infectious disease and inflammation[J]. Annu Rev Immunol, 2011, 30(1):759-795. doi: 10.1146/immunol.2012.30.issue-1 URL
[12]	Rebecca R, Ederveen T, Jos B, et al. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis[J]. Microbiome, 2017, 5(1):63. doi: 10.1186/s40168-017-0278-2 pmid: 28645307
[13]	陈晓欢, 洪学志, 刘雷, 等. 肠道菌群失调与类风湿关节炎[J]. 实用医学杂志, 2019, 35(16):5.
[14]	Pedersen M, Jacobsen S, Klarlund M, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides[J]. Arthritis Res Ther, 2006, 8(4):R133. doi: 10.1186/ar2022 pmid: 16872514
[15]	Lahiri M, Luben RN, Morgan C, et al. Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study)[J]. Ann Rheum Dis, 2014, 73(1):219-226. doi: 10.1136/annrheumdis-2012-202481 pmid: 23505230
[16]	Klareskog L, Rnnelid J, Saevarsdottir S, et al. The importance of differences; On environment and its interactions with genes, and immunity in the causation of rheumatoid arthritis[J]. J Intern Med, 2020, 287(5):514-533. doi: 10.1111/joim.13058 pmid: 32176395
[17]	De Man YA, Bakker-Jonges LE, Goorbergh DVD, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy[J]. Ann Rheu Diseas, 2010, 69(2):420-423.
[18]	Bengtsson C, Malspeis S, Orellana C, et al. Association between menopausal factors and the risk of seronegative and seropositive rheumatoid arthritis: Results from the nurses' health studies[J]. Arthritis Care Res (Hoboken), 2017, 69(11):1676-1684. doi: 10.1002/acr.23194 pmid: 28085997
[19]	Pikwer M, Bergstrom U, Nilsson JA, et al. Early menopause is an independent predictor of rheumatoid arthritis[J]. Ann Rheu Diseas, 2012, 71(3):378-381.
[20]	Sparks JA, Malspeis S, Hahn J, et al. Depression and subsequent risk for incident rheumatoid arthritis among women[J]. Arthritis Care Res(Hoboken), 2021, 73(1):78-89.
[21]	Bookwalter DB, Roenfeldt KA, Leardmann CA, et al. Posttraumatic stress disorder and risk of selected autoimmune diseases among US military personnel[J]. BMC Psychiatry, 2020, 20(1):2. doi: 10.1186/s12888-019-2373-3
[22]	Michot JM, Bigenwald C, Champiat S, et al. Immune-related adverse events with immune checkpoint blockade: A comprehensive review[J]. Eur J Cancer, 2016, 54:139-148. doi: S0959-8049(15)01112-0 pmid: 26765102
[23]	Vaidya B, Adhikari B, Bhochhibhoya M, et al. Late onset dipeptidyl peptidase-4 inhibitor associated seronegative rheumatoid arthritis[J]. J Nepal Health Res Counc, 2021, 19(3):644-646. doi: 10.33314/jnhrc.v19i3.3433 pmid: 35140448
[24]	Reed E, Hedström AK, Hansson M, et al. Presence of autoantibodies in “seronegative” rheumatoid arthritis associates with classical risk factors and high disease activity[J]. Arthritis Res Ther, 2020, 22(1):170. doi: 10.1186/s13075-020-02191-2
[25]	吴滔, 陈楚涛, 杨莉娟, 等. 血清学自身抗体阴性类风湿关节炎患者抗氨基甲酰化蛋白抗体的检测及临床意义[J]. 新医学, 2022, 53(4): 243-248. doi: 10.3969/j.issn.0253-9802.2022.04.004
[26]	Ponikowska M, Wierkot J, Nowak B, et al. Autoantibody and metalloproteinase activity in early arthritis[J]. Clin Rheumatol, 2019, 38(3):827-834. doi: 10.1007/s10067-018-4326-5 pmid: 30406565
[27]	Huang F, Liu X, Cheng Y, et al. Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis[J]. Clin Exp Rheumatol, 2021, 39(5):988-994. doi: 10.55563/clinexprheumatol/vlvlqu pmid: 33427621
[28]	Daigo K, Inforzato A, Barajon I, et al. Pentraxins in the activation and regulation of innate immunity[J]. Immunol Rev, 2016, 274(1):202-217. doi: 10.1111/imr.12476 pmid: 27782337
[29]	Witte T. Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?[J]. Z Rheumatol, 2015, 34(4):629-634.
[30]	Szekanecz Z, Mcinnes IB, Schett G, et al. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases[J]. Nat Rev Rheumatol, 2021, 17(10):585-595. doi: 10.1038/s41584-021-00652-9 pmid: 34341562
[31]	Floudas A, Canavan M, Mcgarry T, et al. ACPA status correlates with differential immune profile in patients with rheumatoid arthritis[J]. Cells, 2021, 10(3):647. doi: 10.3390/cells10030647 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 31

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2023, 38(7): 663-667.
[2]	. [J]. Clinical Focus, 2023, 38(3): 279-284.
[3]	Zhang Yueyue, Xie Meifang, Sun Gen. Rheumatoid arthritis complicated with T-cell large granular lymphocytic leukemia: A case report and literature review [J]. Clinical Focus, 2022, 37(8): 728-732.
[4]	Hu Fangfang, Zhong Shiling, Di Yazhen, Wu Ling. Vascular endothelial function of juvenile idiopathic arthritis in pediatric patients: A systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(3): 204-210.
[5]	Lin Changyi, Song Minghui, Wu Peicheng. Difference between remitting seronegative symmetrical synovitis with pitting edema syndrome and seronegative rheumatoid arthritis [J]. Clinical Focus, 2022, 37(3): 262-265.
[6]	. [J]. Clinical Focus, 2022, 37(2): 188-192.
[7]	. [J]. Clinical Focus, 2022, 37(1): 92-96.
[8]	Liu Ziyi, Wang Jibo. Analysis of clinical characteristics and related factors of rheumatoid arthritis complicated with malignant tumors in patients [J]. Clinical Focus, 2021, 36(3): 246-250.
[9]	. [J]. Clinical Focus, 2021, 36(1): 75-79.
[10]	Chen Wenyu, Wang Juanjuan, Wang Zhiming. Clinical feature of pleural effusion in 78 patients with rheumatoid arthritis [J]. Clinical Focus, 2016, 31(2): 214-217.
[11]	Xie Qingyun, Wei Meng, Fu Peiliang, Sun Jiuyi, Qian Qirong. Association study between single nucleotide polymorphisms of interleukin 23 receptor and rheumatoid arthritis [J]. Clinical Focus, 2016, 31(1): 40-44.
[12]	Wang Lei;Zhang Guimin;Li Li;Yu Zhibo;Yan Yonglong;Zhang Fengxiao;Sun Lijun. Application of high frequency energy Doppler ultrasound in monitoring of rheumatoid arthritis treatment [J]. Clinical Focus, 2015, 30(12): 1405-1409.
[13]	. [J]. Clinical Focus, 2015, 30(12): 1429-1.43014e+007.
[14]	Luo Hong;Chen Yanfei. Expression of interleukin-1β in platelet of patients with rheumatoid arthritis [J]. Clinical Focus, 2015, 30(8): 903-905.
[15]	Xie Qingyun;Wei Meng;Wang Tao;Cheng Yue;Zhu Changliang. Lipid profile in active rheumatoid arthritis and disease activity correlation [J]. Clinical Focus, 2015, 30(8): 906-908914.